Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …

Abstract In sub-Saharan Africa, simple biomarkers of liver fibrosis are needed to scale-up
hepatitis B treatment. We conducted an individual participant data meta-analysis of 3,548 …

Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

We present here the first update of the 2013 EFSUMB (European Federation of Societies for
Ultrasound in Medicine and Biology) Guidelines and Recommendations on the clinical use …

Background Simple and inexpensive non-invasive fibrosis tests are highly needed but have
been poorly studied in sub-Saharan Africa. Methods Using liver histology as a gold …

Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of …

As of 2016, there is no evidence-based pathway to stratify the risk of chronic liver disease in
a general population setting. Non-invasive tests of liver fibrosis might provide a mechanism …

Background Despite the introduction of immunisation for hepatitis B virus (HBV) in the
1990s, HBV-related morbidity and mortality remain high in sub-Saharan Africa. Identification …

Chronic hepatitis B (CHB) continues to be an important public health problem worldwide,
including in the United States. An algorithm for managing CHB was developed by a panel of …

Background Number of non-alcoholic fatty liver disease (NAFLD) cases is increasing over
time due to alteration of food habit, increase incidence of metabolic syndrome, and lack of …